Connect Biopharma Holdings (CNTB) EBITDA (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted EBITDA of -$19.6 million for Q1 2026, down 26.28% sequentially from -$15.5 million in Q4 2025, and down 71.29% YoY from -$68.3 million in Q1 2025.
Connect Biopharma Holdings (CNTB) EBITDA (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported EBITDA for 3 years, with the latest figure at -$19.6 million in Q1 2026.
- Quarterly EBITDA fell 71.29% year-over-year to -$19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.2 million (down 211.45% YoY) and the FY2025 annual result came in at -$58.1 million, down 158.66% from the prior year.
- EBITDA declined to -$19.6 million in Q1 2026 per CNTB's latest filing, from -$15.5 million in the prior quarter.
- Over five years, EBITDA peaked at $13.6 million in Q2 2024 and troughed at -$19.6 million in Q1 2026.
- A 3-year average of -$11.1 million and a median of -$13.4 million in 2025 frame the typical range for EBITDA.
- The widest YoY moves for EBITDA: up 9.39% in 2025, down 198.37% in 2025.
- Over 3 years, EBITDA stood at -$9.6 million in 2024, then slumped by 61.41% to -$15.5 million in 2025, then decreased by 26.28% to -$19.6 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$19.6 million, -$15.5 million, and -$17.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 133.12 Mn |
| 10 | Connect Biopharma Holdings | 144.63 Mn | 144.63 Mn | - | -17.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.60 Mn |
| Mar 31, 2026 | -19.61 Mn |
| Dec 31, 2025 | -15.53 Mn |
| Sep 30, 2025 | -17.68 Mn |
| Jun 30, 2025 | -13.42 Mn |
| Mar 31, 2025 | -11.45 Mn |
| Dec 31, 2024 | -9.62 Mn |
| Sep 30, 2024 | -13.85 Mn |
| Jun 30, 2024 | 13.65 Mn |
| Mar 31, 2024 | -12.63 Mn |